共 6 条
[1]
Chin N.X., Neu H.C., In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin. R–3746, Antimicrobial Agents and Chemotherapy, 32, pp. 671-677, (1988)
[2]
Grellet J., Couraud L., Saux M.C., Roche G., Diffusion pulmonaire du cefixime chez l’homme, La Presse Medicale, 18, pp. 1589-1592, (1989)
[3]
Imaizumi M., Kajita M., Fujita K., Niimi T., Kamiya I., Takahashi T., Et al., Clinical studies on the concentration of cefaclor in sera and lung tissues of patients with respiratory diseases, Japan Journal of Antibiotics, 39, pp. 2754-2760, (1986)
[4]
Jones R.N., Barry A.L., Antimicrobial activity and disk diffusion susceptibility testing of U-76, 253 A (R-3746), the active metabolite of the new cephalosporin ester, U-76, 252 (CS- 807), Antimicrobial Agents and Chemotherapy, 32, pp. 443-449, (1988)
[5]
Tremblay D., Dupront C., Ho C., Coussediere D., Lenfant B., Pharmacokinetics of cefpodoxime in young and elderly volunteers after single doses, Journal of Antimicrobial Chemotherapy, 26, pp. 21-28, (1990)
[6]
Utsui Y., Inoue M., Mitsuhashi S., In vitro and in vivo antibacterial activities of CS– 807 a new oral cephalosporin, Antimicrobial Agents and Chemotherapy, 31, pp. 1085-1092, (1987)